Serenus.AI
Gen-AI technologies for medical treatments pathways and patients' Waiting lists
Startup Seed Health Tech & Life Sciences Est. 2017
Total Raised
$2.7M
Seed
Last Round
$800K
2 rounds
Investors
4
4 public
Team
3
1-10 employees
Confidence
100/100
News
4
articles
Patents
1
About
Serenus.AI specializes in the development of advanced Generative AI technologies that empower medical decisions at critical medical crossroads on patient pathways, saving lives and valuable resources. Our flagship product is the first (registered patent and 4 patents pending) clinically objective, Generative AI, automated case-by-case system to improve decision-making before medical procedures and treatments, while prioritizing patients' waiting lists. Serenus.AI advanced the quality and equality of healthcare delivery, saves valuable resources, and boosts patients', physicians', and payers' satisfaction across the board. The system's algorithms replicate the objective decision-making processes of top physicians by combining up-to-date medical practices, professional knowledge, and machine-learning technologies. The Serenus.AI solution is compatible with every type of health system, including US insurance companies and public health systems. The solution has been validated in practice, and the company is currently active in Europe and the United States with stakeholders in the healthcare field.
Classification
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Core Technology
Artificial IntelligenceDeep Learning
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
pharma-companiesinsurtechhealthcaredata-analyticsemrmachine-learningdeep-learningartificial-intelligenceinsurance-companieshealthcare-providersdigital-healthcaredecision-makingcloud-baseddecision-supportclinical-trials
Funding & Events
Jul 2020
Non-equity $800K
BIRD Foundation
Jul 2018
Seed $1.9M
Firstime VC, thetime, Shibolet, Madanes
News (4)
May 18, 2021 · www.prnewswire.com
growth-positive
Serenus.AI Granted New US Patent for 'AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES'
CustomersPartners
Feb 3, 2021 · www.haaretz.com
growth-positive
Serenus.AI - Innovative AI-based technology for improved medical treatment decisions
CustomersPartners
Sep 14, 2020 · www.prweb.com
growth-positive
Serenus.AI and HealthTrio team up to innovate the authorization process through the use of advanced machine learning
Partners
Jul 13, 2020 · www.birdf.com
BIRD to invest $8 Million in 10 New Projects - BIRD Foundation
Details
Product Stage
Released
Employees
1-10
Exact Count
5
District
Center District
Founded
2017
Registrar
515549145
Crunchbase
medecide
Locations
Rofe ha-Makhtarot St 32, Tel Aviv-Yafo, Israel
Links
Website
LinkedIn
Twitter
Facebook
Careers
Admin
Last Update
Jan 5, 2025
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
markets
Team (3)
Hillary (Orly) Harel
Co-founder & CEO
Founder
Dan Berachowitz
Co-founder
Founder
Prof. Josef Elidan
Co-founder & CMO
Founder
Internal
Created by
Paz Eliav (paze@cet.ac.il)
Created
2016-12-21T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)